Home » Topics » BioWorld Science

BioWorld Science
RSS

TNF levels do not predict TNF blocker success

Feb. 5, 2019

Separating latent from dead HIV genomes

Feb. 5, 2019

NanoViricides advances shingles drug candidate NV-HHV-101 into IND-enabling studies

Feb. 5, 2019

EBV and cancer linked in more ways than one

Feb. 5, 2019

Phase II trial investigates TIMP-GLIA in subjects with celiac disease

Feb. 5, 2019

Aprea initiates phase III study of APR-246 and azacitidine for TP53 mutant MDS

Feb. 5, 2019

I-Mab and BCT to collaborate on arginine depletion therapy

Feb. 5, 2019

Biohaven plans to advance BHV-3500 into phase II for acute treatment of migraine

Feb. 4, 2019

Eisai plans single phase III confirmatory study of BAN-2401 in early Alzheimer's

Feb. 4, 2019

BREEZE-AD1 and AD2 studies of baricitinib in atopic dermatitis meet primary endpoints

Feb. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...